Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05040815 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

Study acronym: INSPIRE
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 3 versions Re-verified since Jul 18, 2023, no change to tracked fieldsv3-v5
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Start date: Jun 2022 to May 11, 2023
    • Study sites: 0 to 1
    • Primary and study completion dates: Jun 2028 to May 2028
    • Secondary endpoints: 8 to 9
    • Eligibility criteria expanded, about 3 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to see whether avoiding preventative radiation to the groin in patients with normal sentinel node biopsy and PET-CT, is at least as effective treating cancer as giving preventative radiation to the groin for patients with anal canal cancer. The investigators also want to know if avoiding radiation to the groin will cause fewer side effects and better quality of life
Trial Details
NCT Number NCT05040815
Lead Sponsor AHS Cancer Control Alberta
Conditions
(from sponsor)		 Anal Canal Cancer
Related terms Anal Canal Carcinoma
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov